test logo 300pxltest logo 300pxltest logo 300pxltest logo 300pxl
  • home
  • science
    • the target: NKCC1
    • the platform
    • the pipeline
    • publications
  • team
  • news
  • contact
✕
IAMA Therapeutics to Showcase NKCC1 Inhibitor Research at the 37th ECNP Congress
24 September 2024
IAMA Therapeutics to Unveil IAMA‑6 at ACS Spring 2025 “First‑Time Disclosures” Session
26 March 2025

IAMA Therapeutics Wins Milan Foreign Press Association’s “Premio Innovazione SEmi”

Milan, Italy — 26 November 2024 — Innovation made in Italy takes center stage once again. IAMA Therapeutics has been honored with the Premio Innovazione SEmi, the annual award bestowed by the Foreign Press Association of Milan to celebrate Italian companies whose breakthrough ideas have public impact and global resonance.

The accolade was accepted by Dr. Laura Cancedda, IAMA’s Founder, together with Paolo Vigo, Board Member, during a ceremony held in the historic Palazzo dei Giureconsulti, just steps from Milan’s iconic Duomo. The setting, rich in Renaissance heritage, underscored the award’s mission: spotlighting forward‑looking enterprises that pair scientific ingenuity with cultural excellence.

Share
iama-3
IAMA Therapeutics S.r.l.
iamatherapeutics@legalmail.it
Vat: 02775040997
Address
Via Filippo Turati, 2
16128 Genoa Italy
Contact
info@iamatherapeutics.com

Cookie Policy - Privacy Policy
Powered by Hetaweb - www.hetaweb.it